Prevention of cardiovascular diseases in perimenopausal women and the influence of hormone replacement therapy: an evidence-based guideline.

نویسندگان

  • Otavio C E Gebara
  • Cesar Fernandes
  • Marcelo C Bertolami
چکیده

Cardiovascular disease/prevention e control; climateric; hormone replacement therapy; guideline; evidence-based medicine. In the position of coordinators/participants of the I Brazilian Guideline for the Prevention of Cardiovascular Diseases in Perimenopausal Women of the journal Arquivos Brasileiros de Cardiologia1 published in the last edition2, we read, somewhat perplexed, the point of view exposed in the article “Hormone Replacement and Cardiovascular Disease: a Guideline Against the Evidence”, and we were rather confused about the considerations made by the author to contradict the study conducted by the multidisciplinary group that developed that guideline.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.

Cardiovascular risk is poorly managed in women, especially during the menopausal transition when susceptibility to cardiovascular events increases. Clear gender differences exist in the epidemiology, symptoms, diagnosis, progression, prognosis and management of cardiovascular risk. Key risk factors that need to be controlled in the perimenopausal woman are hypertension, dyslipidemia, obesity an...

متن کامل

Serum vitamin A status in women users of lowdose oral contraceptives and in postmenopausal women taking hormone replacement therapy.

Background: One of the most important nonenzymatic antioxidant defense systems is vitamin A, and is considered as an important dietary agent for reducing cardiovascular diseases. Objective: The objective of this study was to investigate the serum vitamin A status in women who used low-dose oral contraceptives (OCs) containing 0.15 mg levonorgestrol and 0.03 mg ethinyl estradiol and also in...

متن کامل

بررسی میزان، علل استفاده و عدم استفاده از هورمون درمانی جایگزینی در زنان یائسه مراجعه کننده به درمانگاههای زنان بیمارستان‌های منتخب دانشگاه علوم پزشکی تهران

The present research is a descriptive - analytic study about the rate of use, reasons of use or refusal of Hormone Replacement Therapy in menopausal women referred to gynecology clinics in selected hospitals of Tehran University of Medical Sciences in the year 2001. Samples of research included 400 women age between 40-65 years which selected on accidental basis and collected means was questi...

متن کامل

Point of View Hormonal Replacement and Cardiovascular Disease: a Guideline against the Evidence

Cardiovascular diseases / prevention and control; climacteric; menopause; hormone replacement therapy. The I Brazilian Guideline for the Prevention of Cardiovascular Diseases in Climacteric Women was recently published in the Archives1. The initiative is welcome, but it is evident that, even though it is a joint guideline of the Brazilian Society of Cardiology (SBC) and of the Brazilian Society...

متن کامل

فراوانی هیپرپلازی آندومتر و عوامل خطرساز آن در بیماران سنین 40-60 سالگی مراجعه کننده به بیمارستان شهید یحیی نژاد بابل در فاصله سالهای 82-1379

Background and Aim: Endometrial hyperplasia is the overgrowth of endometrial glands due to prolonged unopposed estrogenic stimulation. Its major clinical symptom is abnormal uterine bleeding (especially perimenopausal). The disease has several risk factors. The aim of this study was to assess the prevalence of endometrial hyperplasia and its risk factors in perimenopausal period in women who re...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Arquivos brasileiros de cardiologia

دوره 93 5  شماره 

صفحات  -

تاریخ انتشار 2009